2 Constitution Ave NE
Washington, DC 20002
During this briefing, panelists will explain the mechanisms of biologic drugs, explore the impact of current regulations on the uptake of biosimilars, and discuss considerations for the biosimilars market in the United States. Coffee and registration check-in will be available at 9:00 a.m.